Haemolytic uraemic syndrome

M Michael, A Bagga, SE Sartain, RJH Smith - The Lancet, 2022 - thelancet.com
Haemolytic uraemic syndrome (HUS) is a heterogeneous group of diseases that result in a
common pathology, thrombotic microangiopathy, which is classically characterised by the …

An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document

JM Campistol, M Arias Ballesteros, G Ariceta, M Blasco… - 2013 - digital.csic.es
[EN] Haemolytic uraemic syndrome (HUS) is a clinical entitydefined as the triad of
nonimmune haemolytic anaemia, thrombocytopenia, and acute renal failure, in which …

Haemolytic uraemic syndrome

D Karpman, S Loos, R Tati… - Journal of internal …, 2017 - Wiley Online Library
Haemolytic uraemic syndrome (HUS) is defined by the simultaneous occurrence of
nonimmune haemolytic anaemia, thrombocytopenia and acute renal failure. This leads to …

Cardiovascular complications in atypical haemolytic uraemic syndrome

M Noris, G Remuzzi - Nature Reviews Nephrology, 2014 - nature.com
Haemolytic uraemic syndrome (HUS) is characterized by nonimmune haemolytic anaemia,
thrombocytopenia and renal impairment—most incidents in childhood are caused by shiga …

Haemolytic uraemic syndrome

F Fakhouri, J Zuber, V Frémeaux-Bacchi, C Loirat - The Lancet, 2017 - thelancet.com
Haemolytic uraemic syndrome is a form of thrombotic microangiopathy affecting
predominantly the kidney and characterised by a triad of thrombocytopenia, mechanical …

[HTML][HTML] Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations

M Salvadori, E Bertoni - World journal of nephrology, 2013 - ncbi.nlm.nih.gov
Hemolytic uremic syndrome (HUS) is a rare disease. In this work the authors review the
recent findings on HUS, considering the different etiologic and pathogenetic classifications …

The global aHUS registry: methodology and initial patient characteristics

C Licht, G Ardissino, G Ariceta, D Cohen, JA Cole… - BMC nephrology, 2015 - Springer
Background Atypical hemolytic uremic syndrome (aHUS) is a rare, genetically-mediated
systemic disease most often caused by chronic, uncontrolled complement activation that …

[HTML][HTML] Atypical hemolytic uremic syndrome (aHUS): treating the patient

J Laurence - Clin Adv Hematol Oncol, 2013 - hematologyandoncology.net
The 3 major thrombotic microangiopathies (TMAs) are thrombotic thrombocytopenic purpura
(TTP), atypical hemolytic uremic syndrome (aHUS), and Shiga toxin–producing Escherichia …

Atypical hemolytic uremic syndrome: from the rediscovery of complement to targeted therapy

F Fakhouri, V Frémeaux-Bacchi, C Loirat - European Journal of Internal …, 2013 - Elsevier
Atypical hemolytic uremic syndrome (aHUS) is a devastating form of renal thrombotic
microangiopathy. In the last five years, we have finally witnessed a dramatic improvement in …

New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab

Ö Köse, LB Zimmerhackl… - … in thrombosis and …, 2010 - thieme-connect.com
Hemolytic uremic syndrome (HUS) is a disease characterized by microangiopathic
hemolytic anemia, consumptive thrombocytopenia, and renal impairment. Often HUS is …